HomeHealthcare & Life SciencesPharmaceuticals Bioidentical Hormones Market

United Arab Emirates Bioidentical Hormones Market Size & Outlook, 2025-2033


United Arab Emirates Bioidentical Hormones Market Insights

  • Reed Intelligence analysis indicates that the United Arab Emirates Bioidentical Hormones Market size, valued at USD 142.69 Million in 2024, is expected to expand to USD 226.35 Million by 2033.
  • The United Arab Emirates market is forecasted to expand at a CAGR of 5.24% spanning 2026–2033.
  • Estrogens held the leading position among By Type segments in 2024, based on market size.
  • Progesterone is projected to post the fastest growth rate, sustaining its position as the most attractive By Type segment during the forecast horizon.

Other Key Findings


  • As of 2024, United Arab Emirates held 3.96% of the global Bioidentical Hormones Market size.
  • By 2033, United States is anticipated to capture the largest share of the global Bioidentical Hormones Market.
  • In Middle East and Africa, United Arab Emirates is expected to lead the regional Bioidentical Hormones Market size by 2033.
  • South Africa will remain the fastest-growing market in Middle East and Africa, reaching USD 71.75 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 142.69 Million
Market Size In 2033 USD 226.35 Million
Largest segment Estrogens
Units Revenue in USD Million
CAGR 5.24% (2025-2033)
Segmnetation Covered
By Type
  1. Estrogens
  2. Progesterone
  3. Testosterone
  4. Others
By Form
  1. Tablets and capsules
  2. Creams and gels
  3. Injectables
  4. Patches and implants
  5. Others
By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
By End-use
  1. Hospitals
  2. Gynecology clinics
  3. Research laboratories
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports